Common genetic pathway can be a conduit to the Pediatric Oncology treatment

Johns Hopkins and Kimmel Cancer Center investigators provide new target for the treatment of these cancers may, discovered the genetic pathway is known in many difficult to treat pediatric brain tumor called a low-grade glioma. The pathway is called the mammalian target of rapamycin in laboratory studies researchers found (mTOR) Pediatric low-grade glioma tumors are very active and, using an experimental drug may block mTOR activity these decreased growth.

View the original article here